Company profile
Dendrogenix company profile
Dendrogenix is a biopharmaceutical company that focuses on developing innovative drugs based on Dendrogenins. These small molecules are designed to address high unmet medical needs, particularly in the areas of deafness and cancer. The company aims to create first-in-class molecules to provide new therapeutic options for patients suffering from these conditions. Dendrogenix's research and development efforts are centered on leveraging the unique properties of Dendrogenins to develop effective treatments for hearing loss and neurological diseases.
Business identity
- Website
- https://dendrogenix.com
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2018-01-01, Year
Headquarters
- Headquarters
- Ligny, Wallonia, Belgium
- Postal code
- 4000
- Country code
- BE
- Continent
- Europe